Get the Stockscreener App
80.03
0.20%
0.16
After Hours:
80.30
0.27
+0.34%
Henry Schein Inc stock is traded at $80.03, with a volume of 2.06M.
It is up +0.20% in the last 24 hours and up +15.70% over the past month.
See More
Previous Close:
$79.87
Open:
$80.46
24h Volume:
2.06M
Relative Volume:
1.36
Market Cap:
$9.32B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
32.80
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+7.06%
1M Performance:
+15.70%
6M Performance:
+10.48%
1Y Performance:
+7.02%
1-Day Range:
$79.33
$80.93
1-Week Range:
$72.74
$81.85
52-Week Range:
$63.67
$82.63
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
80.03 | 9.32B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
604.60 | 78.42B | 330.19B | 2.54B | 4.31B | 19.31 |
|
COR
Cencora Inc
|
258.46 | 50.10B | 293.96B | 1.51B | 3.00B | 7.51 |
|
CAH
Cardinal Health Inc
|
128.26 | 31.24B | 224.34B | 1.26B | 1.08B | 5.14 |
|
PDCO
Patterson Companies Inc
|
30.99 | 2.72B | 6.55B | 155.22M | -823.13M | 1.71 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein (NASDAQ:HSIC) Trading Up 6.2%Here's Why - MarketBeat
What Analysts Are Saying About Henry Schein Stock - Benzinga
KKR builds stake in Henry Schein, reaches deal to add board seats - MSN
Henry Schein gains as KKR reportedly builds stake - MSN
FY2024 EPS Estimates for Henry Schein Reduced by Analyst - MarketBeat
Mizuho raises Henry Schein stock target to $78, keeps neutral stance - Investing.com
American KKR acquired 12% stake in Henry Schein medical company - AK&M News
Swedbank AB Sells 1,626,793 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
KBC Group NV Has $10.25 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
With its stake in Henry Schein, KKR pushes shared ownership of public companies - ImpactAlpha
Root Canal Files Market Growth in Future Scope 2025-2032 | Henry - openPR
Henry Schein gets $250 million investment from private equity firm KKR - Newsday
Henry Schein Partners with KKR for Strategic Growth - TipRanks
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
KKR Builds Stake in Henry Schein With $250M Investment - USA Herald
KKR Plugs $250M Into Healthcare Biz Henry Schein - Law360
Henry Schein, Inc. announced that it expects to receive $250 million in funding from KKR & Co. Inc. - Marketscreener.com
Henry Schein Announces Strategic Investment by KKR - citybiz
KKR builds 12% stake, takes board seats in medical supply company Henry Schein - Axios
KKR takes major stake in medical supply giant Henry Schein - Alternatives Watch
Mizuho Securities Adjusts Henry Schein Price Target to $78 From $75, Maintains Neutral Rating - Marketscreener.com
KKR To Become 12% Shareholder In Henry Schein With Additional $250M Investment: Retail Cheers The Deal - MSN
Henry Schein receives funding - HME News
KKR takes strategic stake in medical supplier Henry Schein - Modern Healthcare
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details - Benzinga
Henry Schein gets a major private equity investment - Mass Device
KKR Takes Strategic Stake in Medical Supplier Henry Schein - BNN Bloomberg
US: KKR ups stake in Henry Schein and gets two seats on the board - Investors in Healthcare
Leerink Adjusts Price Target on Henry Schein to $81 From $73 -January 29, 2025 at 09:08 am EST - Marketscreener.com
KKR Tries Playing the White Knight Against Some Activists - The Wall Street Journal
Henry Schein stock in focus after KKR interest (HSIC:NASDAQ) - Seeking Alpha
Henry Schein (NASDAQ:HSIC) Issues Q4 2024 Earnings Guidance - MarketBeat
KKR boosts investment in Henry Schein, two representatives join board - MSN
Henry Schein Confirms KKR Investment, Board Updates, Sets Q4, 2025 Outlook -January 29, 2025 at 08:37 am EST - Marketscreener.com
KKR to acquire 12% stake in Henry Schein By Investing.com - Investing.com South Africa
Henry Schein (NASDAQ:HSIC) Updates FY 2024 Earnings Guidance - MarketBeat
Henry Schein, Inc. Announces Board Changes -January 29, 2025 at 07:00 am EST - Marketscreener.com
Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal - MarketWatch
Henry Schein announces $250M strategic investment by KKR, board changes - TipRanks
KKR Takes Strategic Stake in Medical Supply Group Henry Schein - Bloomberg
KKR to acquire 12% stake in Henry Schein - Investing.com
KKR builds stake in Henry Schein, agrees deal for board seats, WSJ reports - MSN
KKR boosts investment in Henry Schein, two representatives join board By Investing.com - Investing.com
KKR expands stake in Henry Schein, secures board seats to influence strategy - Private Equity Insights
KKR's Strategic Investment in Henry Schein Boosts Healthcare Supply ChainNews and Statistics - IndexBox, Inc.
Major Deal Alert: KKR Bets Big on Healthcare Giant Henry Schein with $250M Strategic Investment - StockTitan
KKR Increases Stake in Henry Schein to 12% -January 29, 2025 at 06:37 am EST - Marketscreener.com
KKR Builds Stake in Medical-Supply Company, Reaches Deal for Board Seats - MSN
KKR Takes Stake in Henry Schein, The Wall Street Journal Reports -January 29, 2025 at 06:34 am EST - Marketscreener.com
KKR builds stake in Henry Schein, reaches deal for board seats, WSJ reports -January 29, 2025 at 05:45 am EST - Marketscreener.com
KKR Builds Stake in Henry Schein, Agrees Deal for Board Seats, WSJ Reports - U.S News & World Report Money
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.13%
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):